DR5 Antibody (LS-B136)

貨號 Cat. No.
LS-B136
規格 Size
50 µg
品牌 Brand
LSBio

Description

























































































Antibody Catalog ID: LS-B136
Antibody Validation: This antibody replaces catalog number LS-C286. It has been validated for use in the following assays: IHC.
Antibody Target: Tumor Necrosis Factor Receptor Superfamily, Member 10b (TNFRSF10B)
Synonyms: TNFRSF10B, DR5, KILLER, TRAIL Receptor 2, trailr2, TRICK2
Family: TNF Receptor
Subfamily: not assigned-TNF Receptor
Host: TNFRSF10B antibody was produced in Rabbit
Antigen Species: TNFRSF10B antibody was raised against Human
Clonality: Polyclonal
Antigen Type: Synthetic peptide - KLH conjugated
Immunogen: TNFRSF10B antibody was raised against synthetic peptide
Antibody Specificity: peptide corresponding to amino acids near the carboxy terminus of human DR5 precursor
Antigen Modification: C-Terminus
Predicted Species Reactivity: Mouse
Purification: Immunoaffinity Chromatography
Presentation: PBS, 0.02% sodium azide.
Recommended Storage: Long term: -70°C; Short term: +4°C
Antibody Usage Summary: Immunohistochemistry: LS-B136 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody LS-D1, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B136 was determined to be 5-10 ug/ml.
Antibody Uses: Immunohistochemistry - Paraffin (IHC-P) (5 - 10 µg/ml), Immunocytochemistry (ICC), Western blot (WB) (1:250 - 1:500) (Optimal dilution to be determined by the researcher)
Size: 50 µg
Concentration: 1 mg/ml

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢